Not only can antiretroviral therapy provide significant disease-free survival benefits to people living with HIV, it can also greatly curb the spread of the virus and reduce new cases of the infection where treatment is made widely available. But according to a commentary published in the July 1 issue of the Canadian Medical Association Journal, authored by Julio Montaner, MD, and his colleagues at the University of British Columbia, the use of HIV treatment as a prevention strategy has been largely overlooked by public health officials.
The use of treatment as a prevention strategy has long been a major component of public health, including efforts to prevent the ongoing transmission of infections like tuberculosis, syphilis and genital herpes. “However,” Dr. Montaner and his fellow experts write, “public health policymakers and program managers have been reluctant to accept this strategy as viable for preventing the growth of the HIV/AIDS epidemic.”
According to the authors, access to effective antiretroviral therapy has been linked to substantial reductions in new HIV cases in various populations. Research in Taiwan, for example, found a 53 percent reduction in new HIV diagnoses after the introduction of access to combination HIV treatment.
“Treatment as an aid to prevention should be explored in diverse settings, including in developed and developing countries,” the authors write. “Evidence derived from these research efforts will decrease AIDS-related morbidity and mortality and inform policymakers about the role of treatment as an aid to prevention.”
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 3 (of 3 total)
DaleLW, Tucson, 2008-07-04 10:27:20
Go for it......
Mike Jettson, St. Petersburg, 2008-07-02 15:59:38
If I understand this correctly, Dr. Montaner seems to be saying that HIV+ persons have a lower chance of infecting others if they are being treated. While this is intuitively obvious... it flys in the face of what the medical community has been insisting. There's other 'research' out there... but it's a bit sketchy.
John Hopkins, Atlanta, Georgia, 2008-07-02 15:45:57
I have seen private docs use Teneforvir as a preventative agent on a post exposure basis and have suggested it's use for a discordant couple here in Georgia who's relationship was less than one month old. The partners employer's insurance carrier paid for the treatment. So it is being done in a small number of cases but is not the general rule.
People in neighborhoods all over New
York City recognize C. Virginia Fields. For nearly 20 years she played
several major roles in city government—including a seven-year term as
Manhattan Borough President and a run for mayor. Now, as the new
president and CEO of the National Black Leadership Commission on AIDS
(NBLCA), she brings her political energy to a different campaign:
Battling HIV/AIDS in the African-American community.
Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"My first son was born naturally—a month early—and was 8 lbs 7 ounces. I had to work that day and offloaded an 18 wheeler with an electric pallet jack so maybe all that vibration got me started. All four of my kids took AZT and didn't really mind it at all. I would recommend having a nipple put aside just for this because sticking the suction thingy in their mouths did not work so well, for me anyway."
